Zaandam, the Netherlands, March 13, 2018 - Ahold Delhaize has repurchased 989,774 of Ahold Delhaize common shares in the period from March 5, 2018 up to and including March 9, 2018. The shares were repurchased at an average price of €18.32 per share for a total consideration of €18.1 million. These repurchases were made as part of the €2 billion share buyback program announced on November 8, 2017.
The total number of shares repurchased under this program to date is 22,759,369 common shares for a total consideration of €409.8 million.
Download the share buyback transactions excel sheet for detailed individual transaction information from www.aholddelhaize.com/en/investors/share-information/share-buy-back-programs/
This press release is issued in connection with the disclosure and reporting obligation set out in Article 2(2) of the EU Regulation that contains technical standards for buyback programs.


Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion 



